VEGFA and proliferative diabetic retinopathy: Although this effect—the delayed normalization of OIR—is obviously not desirable in this particular model, the anti-VEGF or anti-angiogenic effect of metformin might have beneficial effect on proliferative diabetic retinopathy, in which neovascularization is the core pathology.